ESR1 and breast cancer: In addition, MDA-MB-435S is a triple-negative cell line (estrogen receptor, progesterone receptor and HER2 negative) that belongs to the basal type of breast cancers [38], and that are typically unresponsive to receptor-targeted treatments.